or Try an Advanced Search...

    Technical Analysis for LTRN - Lantern Pharma Inc.

    Grade Last Price % Change Price Change
    F 2.86 -2.72% -0.08
    LTRN closed down 4.55 percent on Wednesday, November 20, 2024, on 1.67 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical LTRN trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish -2.72%
    Lower Bollinger Band Walk Weakness -2.72%
    New 52 Week Low Weakness -2.72%
    Stochastic Reached Oversold Weakness -2.72%
    Below Lower BB Weakness -2.72%
    Down 3 Days in a Row Weakness -2.72%
    Gapped Down Weakness -2.72%
    Lower Bollinger Band Touch Weakness -2.72%
    Oversold Stochastic Weakness -2.72%
    MACD Bearish Signal Line Cross Bearish -7.14%
    Older End-of-Day Signals for LTRN ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 3 hours ago
    60 Minute Opening Range Breakdown about 3 hours ago
    2x Volume Pace about 3 hours ago
    Down 3% about 3 hours ago
    1.5x Volume Pace about 4 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    LTRN Chart by TradingView
    Basic chart:

    Profile

    Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Artificial Intelligence Machine Learning Cybernetics Computational Neuroscience Pharma

    Is LTRN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
    Nov 12 LTRN: Pediatric Rare Cancer in Focus
    Nov 9 Lantern Pharma Inc. (LTRN) Q3 2024 Earnings Call Transcript
    Nov 8 Lantern Pharma Inc (LTRN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...
    Nov 7 Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates
    Nov 5 Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board
    Oct 31 Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
    Oct 23 Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
    Oct 21 Lantern Pharma to Host & Participate in Two Public Webinars During October
    Oct 15 Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
    See more LTRN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.99
    52 Week Low 2.9
    Average Volume 43,004
    200-Day Moving Average 4.97
    50-Day Moving Average 3.57
    20-Day Moving Average 3.38
    10-Day Moving Average 3.41
    Average True Range 0.27
    RSI (14) 36.31
    ADX 23.11
    +DI 12.52
    -DI 22.60
    Chandelier Exit (Long, 3 ATRs) 3.06
    Chandelier Exit (Short, 3 ATRs) 3.71
    Upper Bollinger Bands 3.80
    Lower Bollinger Band 2.96
    Percent B (%b) -0.03
    BandWidth 24.70
    MACD Line -0.09
    MACD Signal Line -0.06
    MACD Histogram -0.0358
    Fundamentals Value
    Market Cap 31.53 Million
    Num Shares 10.7 Million
    EPS -1.39
    Price-to-Earnings (P/E) Ratio -2.12
    Price-to-Sales 0.00
    Price-to-Book 0.98
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.37
    Resistance 3 (R3) 3.41 3.30 3.30
    Resistance 2 (R2) 3.30 3.19 3.28 3.28
    Resistance 1 (R1) 3.12 3.12 3.06 3.08 3.25
    Pivot Point 3.01 3.01 2.98 2.99 3.01
    Support 1 (S1) 2.83 2.90 2.78 2.80 2.63
    Support 2 (S2) 2.72 2.83 2.70 2.60
    Support 3 (S3) 2.54 2.72 2.58
    Support 4 (S4) 2.51